![conference banner](/images/conference-banner.jpeg)
Abstract
The vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) signaling pathway is one of the most important pathways responsible for tumor angiogenesis. Currently, two monoclonal antibodies, anti-VEGF-A antibody Bevacizumab and anti-VEGFR2 antibody Ramucizumab, have been approved for the treatment of solid tumors. At the same time, VEGF/VEGFR2 signaling is involved in the regulation of immune responses. It is reported that the inhibition of this pathway has the capability to promote vascular normalization, increase the intra-tumor infiltration of lymphocytes, and decrease the number and function of inhibitory immune cell phenotypes, including Myeloid-derived suppressor cells (MDSCs), regulatory T cells (Tregs) and M2 macrophages. On this basis, a number of clinical studies have been performed to investigate the therapeutic potential of VEGF/VEGFR2-targeting antibodies plus programmed cell death protein 1 (PD-1)/ programmed cell death ligand 1 (PD-L1) inhibitors in various solid tumor types. In this context, VEGF/VEGFR2- targeting antibodies, Bevacizumab and Ramucizumab are briefly introduced, with a description of the differences between them, and the clinical studies involved in the combination of Bevacizumab/ Ramucizumab and PD-1/PD-L1 inhibitors are summarized. We hope this review article will provide some valuable clues for further clinical studies and usages.
Keywords: Cancer immunotherapy, immune checkpoint inhibitors, combination cancer therapy, PD-1/PD-L1 mechanism, tumor angiogenesis, VEGF/VEGFR2 signaling.
[http://dx.doi.org/10.1016/0360-3016(88)90313-6] [PMID: 3417489]
[http://dx.doi.org/10.1016/0360-3016(92)90840-E] [PMID: 1735668]
[http://dx.doi.org/10.1038/nrc.2016.84] [PMID: 27658636]
[http://dx.doi.org/10.2174/15680096113136660107] [PMID: 24200082]
[http://dx.doi.org/10.1038/nrc.2017.51] [PMID: 28706266]
[http://dx.doi.org/10.1016/j.molmed.2011.01.015] [PMID: 21481637]
[http://dx.doi.org/10.3390/ph3030572] [PMID: 27713269]
[http://dx.doi.org/10.1177/1947601911423030] [PMID: 22866202]
[http://dx.doi.org/10.1177/1947601911423031] [PMID: 22866201]
[http://dx.doi.org/10.1182/blood.V97.3.785] [PMID: 11157498]
[http://dx.doi.org/10.1038/nature00821] [PMID: 12087404]
[http://dx.doi.org/10.1038/nm1096-1096] [PMID: 8837607]
[http://dx.doi.org/10.1634/theoncologist.5-suppl_1-3] [PMID: 10804084]
[http://dx.doi.org/10.1124/pr.56.4.3] [PMID: 15602010]
[http://dx.doi.org/10.20892/j.issn.2095-3941.2015.0070] [PMID: 27458528]
[http://dx.doi.org/10.1038/nrc863] [PMID: 12154350]
[http://dx.doi.org/10.3390/cells8030270] [PMID: 30901976]
[http://dx.doi.org/10.1056/NEJMoa032691] [PMID: 15175435]
[http://dx.doi.org/10.1200/JCO.2006.09.6305] [PMID: 17442997]
[http://dx.doi.org/10.1056/NEJMoa061884] [PMID: 17167137]
[http://dx.doi.org/10.1200/JCO.2007.12.2440] [PMID: 17947719]
[http://dx.doi.org/10.1016/S0140-6736(07)61904-7] [PMID: 18156031]
[http://dx.doi.org/10.1056/NEJMoa1309748] [PMID: 24552320]
[http://dx.doi.org/10.1016/S1470-2045(15)70004-5] [PMID: 25638326]
[http://dx.doi.org/10.1016/S0140-6736(17)31607-0] [PMID: 28756902]
[http://dx.doi.org/10.1056/NEJMoa1104390] [PMID: 22204724]
[http://dx.doi.org/10.1056/NEJMoa1103799] [PMID: 22204725]
[http://dx.doi.org/10.1016/j.ygyno.2013.07.100] [PMID: 23906656]
[http://dx.doi.org/10.1056/NEJMoa072113] [PMID: 18160686]
[http://dx.doi.org/10.1200/JCO.2010.28.0982] [PMID: 21383283]
[http://dx.doi.org/10.1200/JCO.2010.34.1255] [PMID: 21990397]
[http://dx.doi.org/10.1016/S1470-2045(16)30154-1] [PMID: 27501767]
[http://dx.doi.org/10.1016/S0140-6736(13)61719-5] [PMID: 24094768]
[http://dx.doi.org/10.1016/S1470-2045(14)70420-6] [PMID: 25240821]
[http://dx.doi.org/10.1093/annonc/mdv625] [PMID: 26747859]
[http://dx.doi.org/10.1016/S0140-6736(14)60845-X] [PMID: 24933332]
[http://dx.doi.org/10.1016/j.lungcan.2017.07.038] [PMID: 29191593]
[http://dx.doi.org/10.1016/S1470-2045(15)70127-0] [PMID: 25877855]
[http://dx.doi.org/10.1093/annonc/mdw402] [PMID: 27573561]
[http://dx.doi.org/10.1038/s41416-018-0103-0] [PMID: 29808014]
[http://dx.doi.org/10.1016/S1470-2045(18)30937-9] [PMID: 30665869]
[http://dx.doi.org/10.1007/s10456-011-9249-6] [PMID: 22302382]
[http://dx.doi.org/10.1074/jbc.M115.691162] [PMID: 26728464]
[http://dx.doi.org/10.1038/nrd1381] [PMID: 15136787]
[http://dx.doi.org/10.1093/neuonc/noy103] [PMID: 29939339]
[http://dx.doi.org/10.1074/jbc.M307742200] [PMID: 12917408]
[http://dx.doi.org/10.1007/s11912-010-0149-5] [PMID: 21222245]
[http://dx.doi.org/10.1038/sj.leu.2402831] [PMID: 12646950]
[http://dx.doi.org/10.1200/JCO.2012.46.2762] [PMID: 23401453]
[http://dx.doi.org/10.1517/14712598.2013.810717] [PMID: 23803182]
[http://dx.doi.org/10.1007/s00432-014-1862-5] [PMID: 25373315]
[http://dx.doi.org/10.2147/OTT.S166151] [PMID: 30174444]
[http://dx.doi.org/10.1200/JCO.2007.12.3026] [PMID: 17909199]
[http://dx.doi.org/10.1093/annonc/mdw412] [PMID: 27733377]
[http://dx.doi.org/10.1517/14740338.2016.1167186] [PMID: 26982510]
[http://dx.doi.org/10.2147/OTT.S169484] [PMID: 30410364]
[http://dx.doi.org/10.1007/s10120-018-0813-2]
[http://dx.doi.org/10.1093/annonc/mdx514] [PMID: 28950290]
[http://dx.doi.org/10.1200/JCO.2009.23.7537] [PMID: 20048182]
[http://dx.doi.org/10.2340/00015555-2869] [PMID: 29327066]
[http://dx.doi.org/10.1007/s10637-017-0463-y] [PMID: 28391576]
[http://dx.doi.org/10.1001/jamadermatol.2015.1925] [PMID: 26422291]
[http://dx.doi.org/10.1200/JCO.2014.57.1513] [PMID: 25185099]
[http://dx.doi.org/10.2147/OTT.S105862] [PMID: 27574444]
[http://dx.doi.org/10.1126/scitranslmed.aad7118] [PMID: 26936508]
[http://dx.doi.org/10.1186/s40425-018-0316-z] [PMID: 29357948]
[http://dx.doi.org/10.1200/JCO.2017.77.0412] [PMID: 29570421]
[http://dx.doi.org/10.1038/s41568-019-0116-x] [PMID: 30755690]
[http://dx.doi.org/10.1186/s13073-017-0424-2] [PMID: 28420421]
[http://dx.doi.org/10.1016/S1470-2045(15)70076-8] [PMID: 25795410]
[http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.4525]
[http://dx.doi.org/10.1634/theoncologist.2015-0498] [PMID: 27026676]
[http://dx.doi.org/10.1056/NEJMoa1504627] [PMID: 26028407]
[http://dx.doi.org/10.1038/nrclinonc.2016.65] [PMID: 27118494]
[http://dx.doi.org/10.1038/s41573-018-0007-y] [PMID: 30610226]
[http://dx.doi.org/10.1038/d41586-017-08702-7] [PMID: 29293245]
[http://dx.doi.org/10.1056/NEJMoa1816714] [PMID: 30779529]
[http://dx.doi.org/10.1056/NEJMoa1801005] [PMID: 29658856]
[http://dx.doi.org/10.1056/NEJMoa1810865] [PMID: 30280635]
[http://dx.doi.org/10.1016/S1470-2045(16)30366-7] [PMID: 27622997]
[http://dx.doi.org/10.1016/S1470-2045(18)30778-2] [PMID: 30658932]
[http://dx.doi.org/10.1038/nature21724] [PMID: 28371798]
[http://dx.doi.org/10.1152/physrev.00038.2010] [PMID: 21742796]
[http://dx.doi.org/10.2147/OTT.S172042] [PMID: 30410348]
[http://dx.doi.org/10.1111/cei.12069] [PMID: 23600839]
[http://dx.doi.org/10.1126/scitranslmed.aak9679] [PMID: 28404866]
[http://dx.doi.org/10.1007/s10456-017-9552-y] [PMID: 28361267]
[http://dx.doi.org/10.1038/ncomms12624] [PMID: 27571927]
[PMID: 30456891]
[http://dx.doi.org/10.1158/0008-5472.CAN-12-2325] [PMID: 23108136]
[http://dx.doi.org/10.1158/0008-5472.CAN-17-2176] [PMID: 29776963]
[http://dx.doi.org/10.1016/j.it.2011.05.003] [PMID: 21697013]
[http://dx.doi.org/10.1158/2326-6066.CIR-14-0039] [PMID: 24795351]
[http://dx.doi.org/10.1093/annonc/mdx091.010]
[http://dx.doi.org/10.1200/JCO.2017.35.4_suppl.102]
[http://dx.doi.org/10.1200/JCO.2018.36.4_suppl.101]
[http://dx.doi.org/10.1200/JCO.2018.36.4_suppl.92]
[http://dx.doi.org/10.1200/JCO.2019.37.4_suppl.129]
[http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.4047]
[http://dx.doi.org/10.1200/JCO.2017.35.6_suppl.349]
[http://dx.doi.org/10.1634/theoncologist.2018-0044] [PMID: 29853658]
[http://dx.doi.org/10.1200/JCO.2017.35.6_suppl.431]
[http://dx.doi.org/10.1200/JCO.2018.36.6_suppl.578]
[http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.4074]
[http://dx.doi.org/10.1200/JCO.2016.34.15_suppl.2010]
[http://dx.doi.org/10.1158/2326-6066.CIR-17-0640] [PMID: 30755403]
![Wayfinder Image](/images/wayfinder.jpg)